Publication
Number of items: 15.
15 August 2013
  • Investigation of the protein alkylation sites of the STAT3:STAT3 inhibitor Stattic by mass spectrometry. (2013) Sibylle Heidelberger, Giovanna Zinzalla, Dyeison Antonow, Samantha Essex, B. Piku Basu, Jonathan Palmer, Jarmila Husby, Paul J. M. Jackson, Khondaker M. Rahman, Andrew F. Wilderspin, Mire Zloh and David E. Thurston
    • 1 September 2012
  • Target fishing and docking studies of the novel derivatives of aryl-aminopyridines with potential anticancer activity. (2012) S. Erić, J. Antić Stanković, V. Savić, S. Ke, T. Barata, T. Solmajer, Z. Juranić and Mire Zloh
    • 2012
  • Sequences in the HSP90 promoter form G-quadruplex structures with selectivity for disubstituted phenyl bis-oxazole derivatives. (2012) Stephan A. Ohnmacht, Marialuisa Micco, Vanessa Petrucci, Alan K. Todd, Anthony P. Reszka, Mekala Gunaratnam, Marta A. Carvalho, Mire Zloh and Stephen Neidle
    • 2010
  • 2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections. (2010) Deniz Tasdemir, David Sanabria, Ina L Lauinger, Alice Tarun, Rob Herman, Remo Perozzo, Mire Zloh, Stefan H. Kappe, Reto Brun and Néstor M Carballeira
  • An analysis of the 'legal high' mephedrone. (2010) Simon Gibbons and Mire Zloh
    • 2007
  • Discovery of inhibitors of the pentein superfamily protein dimethylarginine dimethylaminohydrolase (DDAH), by virtual screening and hit analysis. (2007) B. Hartzoulakis, S. Rossiter, H. Gill, E. Steinke, P.J. Gane, R. Hurtado-Guerrero, J.M. Leiper, P. Vallance, J. Murray-Rust and D.L. Selwood
    • 1 June 2006
  • NK1 antagonists based on seven membered lactam scaffolds. (2006) J. M. Elliott, E. J. Carlson, G. G. Chcchi, O. Dirat, M. Dominguez, U. Gerhard, R. Jelley, A. B. Jones, M. M. Kurtz, K. I. Tsao and A. Wheeldon
    • 16 May 2005
  • Aryl sulfones : A new class of γ-secretase inhibitors. (2005) M. Teall, P. Oakley, T. Harrison, D. Shaw, E. Kay, J. Elliott, U. Gerhard, J.L. Castro, M. Shearman, R.G. Ball and N.N. Tsou
    • 2005
  • Synthesis and anthelmintic properties of arylquinolines with activity against drug resistant nematodes. (2005) S. Rossiter, J. M. Peron, P.J. Whitfield and K. Jones
    • 23 February 2004
  • Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates. (2004) Mire Zloh, G.W. Kaatz and S. Gibbons
    • 2002
  • Halogenated indole-3-acetic acids as oxidatively activated prodrugs with potential for targeted cancer therapy. (2002) S. Rossiter, L.K. Folkes and P. Wardman
    • 20 August 2001
  • Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists. (2001) Jason Witherington, Vincent Bordas, Dave G. Cooper, Ian T. Forbes, Andrew D. Gribble, Robert J. Ife, Theo Berkhout, Jayneeta Gohil and Pieter H. E. Groot
    • 21 August 2000
  • CCR2B receptor antagonists : Conversion of a weak HTS hit to a potent lead compound. (2000) Ian T. Forbes, David G. Cooper, Emma K. Dodds, Deirdre M. B. Hickey, Robert J. Ife, Malcolm Meeson, Martin Stockley, Theo Berkhout, Jayneeta Gohil, Pieter H. E. Groot and Kitty E. Moores
    • 5 August 1997
  • Synthesis of conformationally constrained analogues of BRL32872 : Determination of stereochemistry and related pharmacological properties. (1997) M. Souchet, M.-C. Forest, B. Cheval, S. Rouanet, J.-F. Faivre, A. Bril, U. Gerhard and R.J. Smith
    • 1 January 1993
  • The free energy change of restricting a bond rotation in the binding of peptide analogues to vancomycin group antibiotics. (1993) U. Gerhard, M.S. Searle and D.H. Williams